218 related articles for article (PubMed ID: 37399424)
1. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor.
Liu D; Ceddia RP; Zhang W; Shi F; Fang H; Collins S
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2307882120. PubMed ID: 37399424
[TBL] [Abstract][Full Text] [Related]
2. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.
Pandey KN
Front Mol Neurosci; 2014; 7():75. PubMed ID: 25202235
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction.
Airhart N; Yang YF; Roberts CT; Silberbach M
J Biol Chem; 2003 Oct; 278(40):38693-8. PubMed ID: 12855709
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Ma X; Iyer SR; Ma X; Reginauld SH; Chen Y; Pan S; Zheng Y; Moroni DG; Yu Y; Zhang L; Cannone V; Chen HH; Ferrario CM; Sangaralingham SJ; Burnett JC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239899
[TBL] [Abstract][Full Text] [Related]
5. The genetic contribution of the natriuretic peptide system to cardiovascular diseases.
Nakayama T
Endocr J; 2005 Feb; 52(1):11-21. PubMed ID: 15758553
[TBL] [Abstract][Full Text] [Related]
6. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.
Potter LR
Pharmacol Ther; 2011 Apr; 130(1):71-82. PubMed ID: 21185863
[TBL] [Abstract][Full Text] [Related]
7. The relaxation induced by uroguanylin and the expression of natriuretic peptide receptors in human corpora cavernosa.
Sousa CM; Havt A; Santos CF; Arnaud-Batista FJ; Cunha KM; Cerqueira JB; Fonteles MC; Nascimento NR
J Sex Med; 2010 Nov; 7(11):3610-9. PubMed ID: 20102442
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide.
Vollmar AM; Schmidt KN; Schulz R
Endocrinology; 1996 May; 137(5):1706-13. PubMed ID: 8612505
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments.
Pandey KN
Mol Cell Biochem; 2002 Jan; 230(1-2):61-72. PubMed ID: 11952097
[TBL] [Abstract][Full Text] [Related]
10. Exercise performance is not improved in mice with skeletal muscle deletion of natriuretic peptide clearance receptor.
Jia B; Hasse A; Shi F; Collins S
PLoS One; 2023; 18(11):e0293636. PubMed ID: 37917630
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.
Patel JB; Valencik ML; Pritchett AM; Burnett JC; McDonald JA; Redfield MM
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H777-84. PubMed ID: 15778276
[TBL] [Abstract][Full Text] [Related]
12. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model.
Jossart C; Coupal M; McNicoll N; Fournier A; Wilkes BC; De Léan A
Biochemistry; 2005 Feb; 44(7):2397-408. PubMed ID: 15709752
[TBL] [Abstract][Full Text] [Related]
13. Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB.
Jiang YS; Lei JY; Chen Y; Jin J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1276-80. PubMed ID: 24699414
[TBL] [Abstract][Full Text] [Related]
14. The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis.
Bodart V; Rainey WE; Fournier A; Ong H; De Léan A
Mol Cell Endocrinol; 1996 Apr; 118(1-2):137-44. PubMed ID: 8735599
[TBL] [Abstract][Full Text] [Related]
15. C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.
Chen Y; Zheng Y; Iyer SR; Harders GE; Pan S; Chen HH; Ichiki T; Burnett JC; Sangaralingham SJ
J Mol Cell Cardiol; 2019 May; 130():140-150. PubMed ID: 30954448
[TBL] [Abstract][Full Text] [Related]
16. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
Matsukawa N; Grzesik WJ; Takahashi N; Pandey KN; Pang S; Yamauchi M; Smithies O
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7403-8. PubMed ID: 10377427
[TBL] [Abstract][Full Text] [Related]
17. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
18. Higher proportions of type C than of types A and B natriuretic peptide receptors exist in the rat ciliary body.
Moya FJ; De Juan JA; Ripodas A; Bernal R; Fernandez-Cruz A; Fernandez-Durango R
Vision Res; 1998 Dec; 38(24):3833-41. PubMed ID: 10211376
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptide system in the human retina.
Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.
Hotchkiss A; Feridooni T; Baguma-Nibasheka M; McNeil K; Chinni S; Pasumarthi KB
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C557-69. PubMed ID: 25631869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
